Detalhe da pesquisa
1.
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Am J Respir Crit Care Med
; 203(2): 202-210, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757963
2.
Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection.
Br J Clin Pharmacol
; 83(4): 742-750, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27792836
3.
Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis.
BMC Immunol
; 15: 585, 2014 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25532536
4.
Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome.
BMC Infect Dis
; 14: 272, 2014 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885072
5.
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
Crit Care
; 16(4): R149, 2012 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22873681
6.
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure.
Cell Rep Med
; 3(3): 100560, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474750